THE SAGE GROUP Finds A Significant Number Of New Pharmaceuticals In Clinical Trials For Treatment Of Peripheral Arterial Disease
Feb 19th 2008Drug InformationCardiovascular
According to a report published by THE SAGE GROUP, research activity has intensified on pharmaceutical treatments for peripheral arterial disease (PAD). “Our analysis found a significant number of new oral therapies in human clinical trials for PAD,” stated Mary L. Yost, author of the report.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
